Apheresis

Aim

discuss current and future apheresis techniques and develop apheresis in less experienced countries

Apheresis involves the removal of whole blood from a patient or donor. Whole blood is separated by a centrifugation or filtration process into the various blood components either plasma (plasmapheresis), platelets (plateletpheresis) or leukocytes (leukapheresis). The remaining blood component(s) are transfused back into the donor/patient. Apart from the collection of donor blood components, apheresis is used for treatment of certain (autoimmune) disorders (e.g. thrombotic thrombocytopenic purpura, sickle cell disease and Multiple Sclerosis). This is done to remove existing harmful substances or cells (e.g. antibodies, cytokines or diseased blood cells) when immunosuppressive or cytotoxic drugs suppress their production.

About

We focus on the various apheresis technologies; assess new equipment, collection methods and materials in order to improve the current methods. We are also interested in the quality, safety and storage of blood components collected by apheresis methods. We are setting up various educationaland training programs related to (the latest) apheresis technologies with a special focus on developing countries or inexperienced blood banks.

Our Chairperson is Hans Vrielink.

 

 

Activities

Apart from meeting at the biannual ISBT congresses, training and educational programs are discussed and set up.

Joining the WP

Interested in joining the Apheresis WP? Please email our Chairperson.

 

 

GET IN TOUCH

Hans Vrielink

Hans Vrielink

Chairperson

E-mail
Sanquin Blood Supply
Blood Transfusion Technology
Amsterdam, the Netherlands

OTHER WORKING PARTIES